Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa, Asia, Europe, Oceania, and South America. The aim of this
research study is to compare the efficacy (reduction in HbA1c and in blood glucose levels) of
insulin detemir compared to NPH insulin administered as basal insulin for the treatment of
type 1 diabetes and to verify the safety of use (number and severity of episodes of
hypoglycemia, body weight, and insulin antibodies and side effects).